12:00 AM
 | 
Jun 12, 2006
 |  BC Week In Review  |  Company News  |  Deals

Spectrum Pharmaceuticals, Altair deal

The companies resolved their arbitration related to milestone payments under a 2005 deal in which SPPI received exclusive worldwide rights to develop...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >